| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 10/04/2006 | CN1277840C Growth hormone releasing compound for treating tumor and inhibitor thereof |
| 10/04/2006 | CN1277836C Human angiogenin antisense oligonucleotide and pharmaceutical composition |
| 10/04/2006 | CN1277822C Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof |
| 10/04/2006 | CN1277561C Disinfecting tumour-decomposition powder |
| 10/04/2006 | CN1277545C Use of bisphosphonates in preparing medicine for the treatment of bone metastasis associated with prostate cancer |
| 10/04/2006 | CN1277543C Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 10/04/2006 | CN1277541C Use of ATase inhibitor in preparing synergistic pharmaceutical composition for human cancer cell toxicity |
| 10/04/2006 | CN1277537C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
| 10/03/2006 | US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115743 For treatment of leukemia, carcinomas, adenocarcinomas, and melanoma; assaying metabolism via cytochromes |
| 10/03/2006 | US7115740 Pyrimido compounds having antiproliferative activity |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115729 Isolated nucleic acid molecules which encode peptides which bind to MHC class II molecules, such as HLA-DR53 |
| 10/03/2006 | US7115720 Structurally distinct radionuclide complexes of multinitrogen heterocycles having phosphonic acid groups that target bone, and thus, are useful as imaging and therapeutic agents (e.g., for bone marrow suppression, cancer, bone pain) |
| 10/03/2006 | US7115707 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 10/03/2006 | US7115637 Inhibitors of p38 |
| 10/03/2006 | US7115634 4-aminopiperidine and their use as a medicine |
| 10/03/2006 | US7115631 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 10/03/2006 | US7115619 N8, N13 -disubstituted quino[4,3,2-kl]acridinium salts as therapeutic agents |
| 10/03/2006 | US7115617 Anticarcinogenic and kinase inhibitor; a heteroaryl(containing atleast one oxygen or sulfur atom)amino substituted pyrimidine compound |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115594 Administering to a patient with metabolic bone disease an effective amount of 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 compound to treat osteoporosis |
| 10/03/2006 | US7115589 Phosphorus-containing moietys; kinase inhibitors; improve balance of bone growth relative to bone resorption; inhibit PTH-induced bone resorption; cytotoxic or growth inhibitory effect on cancer cell lines |
| 10/03/2006 | US7115576 Water-soluble antibiotic comprising an amino sugar, in the form of a polysaccharide conjugate |
| 10/03/2006 | US7115573 Prodrug compounds with an isoleucine |
| 10/03/2006 | US7115556 Use of anti-prolactin agents to treat proliferative conditions |
| 10/03/2006 | US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115380 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115360 Isolation and use of solid tumor stem cells |
| 10/03/2006 | US7115267 polypeptide comprising hemoglobin alpha chain wherein the C-terminal hydrophobic domain has been substituted or deleted; regulating stem cell cycle and accelerating the post-chemotherapy peripheral blood cell recovery; inhibitors and stimulators of stem cell proliferation. |
| 10/03/2006 | US7115261 Combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target. |
| 10/03/2006 | US7115257 Delivering a growth factor to a host having a retinal degenerative disorder by administering an encapsulated ARPE-19 cell genetically engineered to secrete CNTF within a semipermeable membrane, especially by implantation |
| 10/03/2006 | US7114966 Apparatus for a quick release safety connector assembly |
| 10/03/2006 | CA2474211C Antiproliferative quinazolines |
| 10/03/2006 | CA2288046C Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 10/03/2006 | CA2268840C Benzimidazole-2-carbamates for the treatment of viral infections and cancer |
| 10/03/2006 | CA2249348C Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 10/03/2006 | CA2234638C New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
| 10/03/2006 | CA2224764C A process for preparing epirubicin or acid addition salts thereof from daunorubicin |
| 10/03/2006 | CA2189221C Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 10/03/2006 | CA2080504C Pharmaceutical compositions comprising il-6 |
| 09/28/2006 | WO2006102363A1 Methods for treating or preventing acute myelogenous leukemia |
| 09/28/2006 | WO2006102112A2 Prokineticin 1 receptor |
| 09/28/2006 | WO2006102079A1 N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase |
| 09/28/2006 | WO2006101937A1 Acylhydrazones as kinase modulators |
| 09/28/2006 | WO2006101846A1 Dosing regimen of flavopiridol for treating cancer in particular cll |
| 09/28/2006 | WO2006101692A1 Anti-ctla4 antibody and indolinone combination therapy for treatment of cancer |
| 09/28/2006 | WO2006101691A1 Therapy of prostate cancer with ctla4 antibodies and hormonal therapy |
| 09/28/2006 | WO2006101535A1 Inhibition of proteasome function to potentiate the proapoptotic and antitumor activity of cytokines |
| 09/28/2006 | WO2006101456A1 Bicyclic heterocycles hydroxamate compounds useful as histone deacetylase (hdac) inhibitors |
| 09/28/2006 | WO2006101455A1 Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 09/28/2006 | WO2006101434A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS |
| 09/28/2006 | WO2006101273A1 Prophylactic/therapeutic agent for cancer |
| 09/28/2006 | WO2006101244A2 Method and composition for treating mucosal disorders |
| 09/28/2006 | WO2006101205A1 Method for activation of t cells and kit for production of activated t cells |
| 09/28/2006 | WO2006101103A1 Agent for treatment of hematopoietic tumor |
| 09/28/2006 | WO2006101102A1 Agent for treatment of solid tumor |
| 09/28/2006 | WO2006101073A1 Anti-cancer agent and bacterium capable of producing novel compound prunustatin |
| 09/28/2006 | WO2006101052A1 Novel acetylene derivative |
| 09/28/2006 | WO2006100797A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 09/28/2006 | WO2006100582A1 Antigen binding molecules directed to mcsp and having increased fc receptor binding affinity and effector function |
| 09/28/2006 | WO2006100461A1 2-AZETIDINYL-4-(lH-PYRAZOL-3-YLAMINO)PYRIMIDINES AS INHIBITORS OF INSULIN-LIKE GROWTH FACTOR-I RECEPTOR ACTIVITY |
| 09/28/2006 | WO2006100439A1 Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer |
| 09/28/2006 | WO2006100213A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 09/28/2006 | WO2006100195A1 Use of macrolides for treating intestinal inflammation |
| 09/28/2006 | WO2006099974A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents |
| 09/28/2006 | WO2006099875A1 Antibodies against cd38 for treatment of multiple myeloma |
| 09/28/2006 | WO2006099804A1 Herbal compositions useful in cancer treatment |
| 09/28/2006 | WO2006099739A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | WO2006099685A1 Method for the prophylaxis or treatment of carcinomas |
| 09/28/2006 | WO2006099681A1 Isoflavonoid dimers |
| 09/28/2006 | WO2006099667A1 Prophylactic and therapeutic agents and uses therefor |
| 09/28/2006 | WO2006077426A3 4- (2, 6-DICHLOROBENZOYLAMINO) -lH-PYRAZOLE-3 -CARBOXYLIC ACID PIPERIDIN- 4 -YLAMID ACID ADDITION SALTS AS KINASE INHIBITORS |
| 09/28/2006 | WO2006067867A8 Cell adhesion factor expression inhibitor |
| 09/28/2006 | WO2006061258A3 Cytotoxic agents comprising new taxanes |
| 09/28/2006 | WO2006057998A8 Binary antitumor compositions platinum (iv) derivatives |
| 09/28/2006 | WO2006053342A3 Integrin antagonists useful as anticancer agents |
| 09/28/2006 | WO2005082459A3 Method of decreasing blood cells |
| 09/28/2006 | WO2005021776A3 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
| 09/28/2006 | US20060217553 chemical preparation of diketopiperizine derivatives; useful as anticarcinogenic and antifungal agent |
| 09/28/2006 | US20060217551 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 09/28/2006 | US20060217536 Monoclonal antibody that has an extremely high binding ability to human ZAQL-1 and can neutralize or inhibit its activity, useful for diagnosing, preventing and treating endometrial cancer, endometriosis or ovulation disorders. |
| 09/28/2006 | US20060217442 Preventive or ameliorating agent for liver disease involving hepatopathy |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217402 Biocidal compounds and their preparation |
| 09/28/2006 | US20060217388 Phthalazine derivatives for treating inflammatory diseases |
| 09/28/2006 | US20060217382 Imidazotriazine compounds |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217363 Methods and therapeutic combinations for the treatment of hypercholesterolemia and xanthoma using sterol absorption inhibitors |
| 09/28/2006 | US20060217353 24-sulfoximine vitamin D3 compounds |
| 09/28/2006 | US20060217342 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 09/28/2006 | US20060217339 Breast cancer, prostate cancer, brain cancer, head and neck cancer, myeloma, melanoma, leukemia and lymphoma; promotion of apoptosis; may have phosphorothioate, 2'-O-(2-methoxyethyl) sugar, and/or 5-methyl cytosine modifications; useful prophylactically, and as clinical research and diagnostic tools. |
| 09/28/2006 | US20060217299 Degradation inhibitor for hepatitis b virus x interacting protein |
| 09/28/2006 | US20060217297 Dimerized peptide |